CalciMedica
CALC
31 hedge funds and large institutions have $8.39M invested in CalciMedica in 2026 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 6 closing their positions.
1,861% more capital inflows, than outflows
Capital inflows: $5.45M | Capital outflows: $278K
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
45.71% more ownership
Funds ownership: 6.97% → 52.68% (+46%)
15% more funds holding
Funds holding: 27 → 31 (+4)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Woodline Partners
San Francisco,
California
|
+$1.77M |
| 2 |
HCM
Heights Capital Management
San Francisco,
California
|
+$1.1M |
| 3 |
SCM
Squadron Capital Management
Westmont,
Illinois
|
+$883K |
| 4 |
SC
Stempoint Capital
New York
|
+$883K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$441K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$96.4K |
| 2 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
-$56.8K |
| 3 |
180 Wealth Advisors
Federal Way,
Washington
|
-$30.6K |
| 4 |
Stonehage Fleming Financial Services
St. Helier,
Jersey
|
-$29K |
| 5 |
Renaissance Technologies
New York
|
-$21.8K |
CALC Hedge Fund Activity: Q2 2026 in Review
31 of the 8,358 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q2 2026, worth a combined $8.39M — up 1,316% from $593K a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new CALC positions and 6 closed out — a net gain of 4 holders — while 4 added to existing stakes and 6 trimmed.
The largest buyer was Woodline Partners, opening a new position worth an estimated $1.77M. The largest seller was Jane Street, exiting entirely with an estimated $96.4K sold.
- 31 institutional investors held CalciMedica (CALC) as of Q2 2026, up from 27 in Q1 2026.
- Funds reported $8.39M of CalciMedica stock for Q2 2026, up 1,316% quarter-over-quarter.
- 10 funds opened new CalciMedica positions in Q2 2026 and 6 closed out, a net change of +4 holders.
- The largest CalciMedica buyer in Q2 2026 was Woodline Partners, an estimated $1.77M added.
- The largest CalciMedica seller in Q2 2026 was Jane Street, an estimated $96.4K sold.
Based on aggregated 13F filings for Q2 2026.